Machine learning for biomarker identification in cancer research - developments toward its clinical application

Area of Science:

• Oncology
• Bioinformatics
• Artificial Intelligence

Background:

• Personalized cancer treatment relies on identifying molecular subtypes from patient tumor profiles and clinical data.
• Existing computational algorithms struggle to classify complex patterns from vast, emerging cancer research data.
• A need exists for advanced computational tools to improve cancer diagnosis, prognosis, and therapeutic strategies.

Purpose of the Study:

• To review the current applications of machine learning (ML) in cancer research.
• To highlight trends, achievements, and challenges of ML implementation in clinical oncology.

Main Methods:

• Systematic literature review of machine learning applications in cancer research.
• Analysis of identified patterns in molecular profiles and clinical metadata.
• Focus on artificial intelligence-driven pattern recognition in complex cancer datasets.

Main Results:

• Machine learning demonstrates significant potential for pattern recognition in cryptic cancer datasets.
• ML applications are increasingly evident in cancer diagnosis, prognosis, and therapeutic development.
• Identified patterns can guide personalized treatment strategies for specific molecular subtypes.

Conclusions:

• Machine learning offers powerful tools for deciphering complex cancer data.
• Further development and validation are crucial for integrating ML into clinical practice.
• Addressing current roadblocks will facilitate the widespread adoption of ML in cancer care.